2010
DOI: 10.1016/j.cca.2010.07.002
|View full text |Cite
|
Sign up to set email alerts
|

Functional vascular endothelial growth factor gene polymorphisms and diabetes: Effect on coronary collaterals in patients with significant coronary artery disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
25
1
3

Year Published

2011
2011
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 41 publications
(31 citation statements)
references
References 37 publications
2
25
1
3
Order By: Relevance
“…Demonstration of non-infarct-related artery chronic total occlusion (CTO) rates within groups (12.7% vs. 2.5%, p < 0.001); ICD -inadequate collateral development; ACD -adequate collateral development which leads to induced coronary narrowing and collateral supplying; however, previous clinical and experimental studies on collateral development, particularly in diabetic patients, have reported conflicting results. It is known that endothelial dysfunction, decreased nitric oxide (NO) synthesis, decreased endothelial progenitor cell (EPC) proliferation, and impaired vascular endothelial growth factor (VEGF)-induced EPC proliferation are well-known characteristics of DM [8,18,19]. In contrast, these factors are crucial for collateral development.…”
Section: Discussionmentioning
confidence: 99%
“…Demonstration of non-infarct-related artery chronic total occlusion (CTO) rates within groups (12.7% vs. 2.5%, p < 0.001); ICD -inadequate collateral development; ACD -adequate collateral development which leads to induced coronary narrowing and collateral supplying; however, previous clinical and experimental studies on collateral development, particularly in diabetic patients, have reported conflicting results. It is known that endothelial dysfunction, decreased nitric oxide (NO) synthesis, decreased endothelial progenitor cell (EPC) proliferation, and impaired vascular endothelial growth factor (VEGF)-induced EPC proliferation are well-known characteristics of DM [8,18,19]. In contrast, these factors are crucial for collateral development.…”
Section: Discussionmentioning
confidence: 99%
“…Differences in coronary collateral growth may be one of the pathophysiological mechanisms responsible for the J-curve phenomenon in the relationship between diastolic blood pressure and cardiovascular risk. In experimental animal studies, hyperlipidemia, particularly hypercholesterolemia, was shown to be an inhibitor of arteriogenesis (Lin et al, 2010). However, data on the relationship between coronary collateral formation and hyperlipidemia remain controversial, partly because of the use of different techniques for grading the collateral flow (van der Hoeven et al, 2013).…”
Section: Traditional Risk Factorsmentioning
confidence: 99%
“…Reduced VEGF secretion was reportedly linked to poor pregnancy outcomes, including fetal loss (3,4). VEGF expression is genetically controlled, and polymorphisms in the VEGF gene were identified, some of which [þ405C>G (rs2010963) and À2578C>A (rs699947)] were associated with altered VEGF production (5,6).…”
mentioning
confidence: 99%